Glenmark Pharmaceuticals Limited

GLENMARK.BO·BSE·Healthcare
Compare
2,485.50−16.35 (−0.65%)today
At close: Nov 5, 3:28 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2,501.85
Open2,540.70
Day range2,459.252,540.70
52-week range1,800.002,540.70
Off day high−2.17%
Off 52-week high−2.17%
Volume19.68K
Avg. volume (3M)20.04K
Market cap701.47B
EPS (TTM)63.69
Forward P/E25.62
P/E ratio (TTM)39.02
Dividend yield0.20% (5.00)
Beta (5Y)0.27
Shares outstanding282.22M
Short interest—
Earnings dateNov 5, 2026
Analyst target2,512.82
Profit margin10.14%

Against its peers

Compare in full ›
GLENMARK.BO IPCALAB.NS JUBLPHARMA.BO 300558.SZ 4119.TW 6998.HK
Market cap 701.47B 494.62B 150.00B 20.76B 6.05B 3.11B
P/E (TTM) 39.0 37.8 42.7 77.9 99.2 9.9
Forward P/E 25.6 27.7 18.7 29.2 9.0 -1.9
Price/book 6.7 6.1 2.1 3.2 1.1 0.7
Dividend yield 0.20% 0.30% 0.53% 0.31% 1.47% —
1-year change +38.17% +51.13% −19.11% −12.57% −9.43% −45.69%
Today −0.65% −1.14% +0.79% +1.62% −0.59% +0.32%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.

Kalkine India·Positive

Glenmark Pharmaceuticals Adapalene Gel Pump Pack US Launch

Kalkine India Glenmark Pharmaceuticals (NSE:GLENMARK): Why Did It Launch Adapalene Gel in Pump Packs in the US? Source: Krish Capital Pty Ltd Glenmark Pharmaceuticals (NSE:GLENMARK) announced on 6 October 2026 that its US subsidiary, Glenma

From the 4Search news index, newest first.

In the news

2mentions in 30 days
2with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance